Wholesale Trader of a wide range of products which include inactivated hepatitis a vaccine adsorbed ip, bevac hepatitis b vaccine 10ml, fluquadri vaccine flu vaccine, cervavac haemophilus influenzae injection, bcg onco 40 mg vaccine and mr-vac vaccine.
Havshield 250IU Injection protects against hepatitis A, which is a serious liver disease caused by the hepatitis A virus (HAV), that spreads via contact with contaminated food or water. It is given as 2 shots, 6 to 12 months apart. Both shots are needed for long-term protection.
Hepatitis B Vaccine (rDNA) and Aluminium Hydroxide which prevent Hepatitis B, and Thiomersal as the
Treatment
Hepatitis B Vaccine (rDNA) vaccine helps develop immunity by initiating a mild infection.
Bevac Vaccine is an active immunizing agent. It is used for the prevention of hepatitis B infection in individuals considered at risk of exposure to hepatitis B virus.
vaccine that has been inactivated – made from a dead virus
Treatment
ગુજરાતીમાં In English Fluquadri PFS Vaccine 5x0. 5 ml is an immunizing medicine used in the preventi
Storage Temp
2–8°C
Country of Origin
Made in India
Fluquadri PFS Vaccine 5x0. 5 ml is an immunising agent or vaccine to prevent influenza in children and adults. It protects against four types of virus strains present in the vaccine and other closely related strains. It acts by stimulating the immune system to produce antibodies against the influenza virus.
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant (20mcg)
Packaging Size
0.5ml
Treatment
Prevention of HPV-associated cancers
Prescription/Non prescription
Prescription
Packing Type
box
Item Name
Cervavac Vaccine
Human papillomavirus (HPV) can cause many cancers, including cervical, vaginal, vulvar, and anal cancers. The vaccine works by stimulating the immune system to create antibodies that protect against these high-risk HPV strains. Early vaccination, especially before exposure to the virus, offers long-term protection and significantly reduces the risk of developing these serious cancers, contributing to better health outcomes. It is normally given between the ages of 9 and 26.